Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp, distributes pharmaceutical and healthcare products. The company provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceuticals, medical products and supplies, and other healthcare products. It also serves hospitals, primary health service institutions, and retail drug stores. Sinopharm also manufactures and sells pharmaceuticals, chemical reagents, laboratory supplies, and carries out the development of pharmaceutical, medical services, and other health-related industries. The group also manages a chain of medicine stores in China through direct operations and franchises to market pharmaceutical and healthcare products. Sinopharm is headquartered in Shanghai, China.
Headquarters
China
Address
Sinopharm Group Building, No. 385, East, Shanghai, 200023
Website
www.sinopharmholding.com
Telephone
86 21 23052666
No of Employees
112,859
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
1099 (HKG)
Revenue (2022)
$80.8B
14.2%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
7.9%
(2022 vs 2021)
Market Cap*
$8.6B
Net Profit Margin (2022)
XYZ
-5.1%
(2022 vs 2021)
* As of and is in US$
Sinopharm Group Co Ltd premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Chemical Reagents | Pharmaceutical and Healthcare Products Distribution and Logistics |
| Laboratory Supplies | Other Services |
| Medical Equipments | Retail Drug Stores |
| XYZ | |
| XYZ | |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2022 | Contracts/Agreements | In November, the company and Merck Sharp & Dohme (MSD) entered into an agreement on the import and distribution of COVID-19 pill Molnupiravir in China. |
| 2022 | Contracts/Agreements | In October, the company entered into an agreement with Natong Group to procure medical devices including orthopedic consumables, surgical instruments and other related or auxiliary products as well as masks and other pandemic prevention materials from the Natong Group. |
| 2022 | Contracts/Agreements | In June, the company's Sinopharm Xingsha entered into an agreement with ChromaDex Corp to accelerate cross-border sales of Tru Niagen into mainland China. |
Competitor Comparison
| Key Parameters | Sinopharm Group Co Ltd | Shanghai Fosun Pharmaceutical (Group) Co Ltd | China Resources Sanjiu Medical & Pharmaceutical Co Ltd | Tasly Pharmaceutical Group Co Ltd | Wai Yuen Tong Medicine Holdings Ltd |
|---|---|---|---|---|---|
| Headquarters | China | China | China | China | Hong Kong |
| City | Shanghai | Shanghai | Shenzhen | Tianjin | Hong Kong |
| State/Province | Shanghai | Shanghai | Guangdong | Tianjin | - |
| No. of Employees | 112,859 | 36,279 | 15,420 | 9,437 | 1,928 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Yu Qingming | Chairman | Executive Board | 2021 | 58 |
| Li Xiaojuan | Chief Financial Officer | Senior Management | 2021 | 46 |
| Liu Yong | President; Director | Executive Board | 2017 | 53 |
| Cai Maisong | Vice President | Senior Management | 2018 | 52 |
| Wu Yijian | Secretary | Senior Management | 2019 | 52 |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward